Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterus | 17 | 2025 | 587 | 4.180 |
Why?
|
| Endometrium | 16 | 2025 | 290 | 3.210 |
Why?
|
| Embryo Implantation | 11 | 2025 | 235 | 2.450 |
Why?
|
| Transforming Growth Factor beta | 6 | 2025 | 488 | 2.310 |
Why?
|
| Endometriosis | 10 | 2024 | 186 | 2.260 |
Why?
|
| Decidua | 6 | 2024 | 142 | 1.470 |
Why?
|
| Signal Transduction | 16 | 2025 | 4936 | 1.450 |
Why?
|
| Proteomics | 2 | 2023 | 604 | 1.120 |
Why?
|
| Endometrial Neoplasms | 2 | 2019 | 116 | 1.100 |
Why?
|
| Estrogen Receptor beta | 4 | 2016 | 86 | 1.040 |
Why?
|
| Uterine Diseases | 2 | 2025 | 25 | 0.940 |
Why?
|
| Infertility | 2 | 2024 | 82 | 0.940 |
Why?
|
| Receptors, Progesterone | 7 | 2024 | 899 | 0.910 |
Why?
|
| Estrogens | 7 | 2024 | 525 | 0.890 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2024 | 130 | 0.870 |
Why?
|
| Pregnancy | 19 | 2025 | 7600 | 0.850 |
Why?
|
| Infertility, Female | 3 | 2021 | 151 | 0.800 |
Why?
|
| Smad Proteins | 1 | 2023 | 43 | 0.800 |
Why?
|
| Lactoferrin | 1 | 2022 | 78 | 0.730 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2021 | 6 | 0.710 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2023 | 235 | 0.690 |
Why?
|
| Epithelium | 4 | 2023 | 365 | 0.670 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 709 | 0.670 |
Why?
|
| Uterine Neoplasms | 7 | 2019 | 112 | 0.630 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 259 | 0.630 |
Why?
|
| Pregnancy Complications | 1 | 2024 | 553 | 0.600 |
Why?
|
| Placenta | 3 | 2022 | 550 | 0.590 |
Why?
|
| Female | 41 | 2025 | 72035 | 0.570 |
Why?
|
| Premature Birth | 1 | 2022 | 419 | 0.550 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2017 | 24 | 0.540 |
Why?
|
| Animals | 25 | 2025 | 36521 | 0.530 |
Why?
|
| Neoplasms | 2 | 2023 | 3035 | 0.530 |
Why?
|
| Fertility | 3 | 2023 | 270 | 0.520 |
Why?
|
| Carcinogenesis | 2 | 2019 | 363 | 0.520 |
Why?
|
| Leiomyoma | 6 | 2015 | 85 | 0.510 |
Why?
|
| Ovarian Diseases | 2 | 2015 | 28 | 0.500 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2015 | 31 | 0.490 |
Why?
|
| Immediate-Early Proteins | 1 | 2016 | 60 | 0.480 |
Why?
|
| Mice | 16 | 2024 | 19045 | 0.440 |
Why?
|
| Smad5 Protein | 3 | 2024 | 22 | 0.430 |
Why?
|
| Eicosanoids | 1 | 2012 | 13 | 0.380 |
Why?
|
| Mice, Knockout | 9 | 2024 | 4012 | 0.370 |
Why?
|
| Smad1 Protein | 2 | 2022 | 23 | 0.370 |
Why?
|
| Placentation | 4 | 2017 | 61 | 0.370 |
Why?
|
| Protein Kinases | 2 | 2023 | 345 | 0.360 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 1070 | 0.360 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 196 | 0.350 |
Why?
|
| Activin Receptors, Type I | 2 | 2024 | 36 | 0.340 |
Why?
|
| Humans | 35 | 2025 | 134194 | 0.320 |
Why?
|
| Reproduction | 1 | 2012 | 244 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 612 | 0.320 |
Why?
|
| Glucocorticoids | 1 | 2012 | 401 | 0.310 |
Why?
|
| Smad2 Protein | 2 | 2019 | 53 | 0.310 |
Why?
|
| Smad3 Protein | 2 | 2019 | 59 | 0.300 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 1922 | 0.300 |
Why?
|
| Progesterone | 3 | 2024 | 636 | 0.290 |
Why?
|
| Parturition | 2 | 2022 | 67 | 0.270 |
Why?
|
| Estradiol | 3 | 2021 | 560 | 0.270 |
Why?
|
| Neoplastic Stem Cells | 3 | 2015 | 352 | 0.260 |
Why?
|
| Blastocyst | 2 | 2017 | 79 | 0.250 |
Why?
|
| Cell Proliferation | 6 | 2019 | 2562 | 0.250 |
Why?
|
| Activin Receptors, Type II | 2 | 2024 | 33 | 0.240 |
Why?
|
| Neoplasm Proteins | 2 | 2024 | 719 | 0.230 |
Why?
|
| Aminopyridines | 1 | 2024 | 60 | 0.210 |
Why?
|
| Receptors, FSH | 1 | 2023 | 20 | 0.210 |
Why?
|
| DNA | 3 | 2024 | 1685 | 0.210 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 276 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 187 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2023 | 76 | 0.190 |
Why?
|
| Phosphotransferases | 1 | 2021 | 41 | 0.180 |
Why?
|
| Mammals | 1 | 2022 | 283 | 0.170 |
Why?
|
| Cell Survival | 3 | 2024 | 890 | 0.170 |
Why?
|
| Aromatase | 2 | 2023 | 26 | 0.170 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 771 | 0.170 |
Why?
|
| Oviducts | 1 | 2021 | 338 | 0.170 |
Why?
|
| Fallopian Tubes | 1 | 2021 | 78 | 0.170 |
Why?
|
| Stromal Cells | 3 | 2017 | 314 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 4802 | 0.170 |
Why?
|
| Cell Differentiation | 4 | 2023 | 2044 | 0.160 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 308 | 0.160 |
Why?
|
| Organoids | 1 | 2023 | 300 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2021 | 352 | 0.150 |
Why?
|
| Biomarkers | 2 | 2021 | 3433 | 0.150 |
Why?
|
| Homeostasis | 1 | 2023 | 751 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2021 | 458 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 2137 | 0.140 |
Why?
|
| DNA Methylation | 3 | 2015 | 1148 | 0.140 |
Why?
|
| Genitalia | 1 | 2017 | 39 | 0.140 |
Why?
|
| Trophoblasts | 2 | 2015 | 122 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 356 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2015 | 1070 | 0.140 |
Why?
|
| Follistatin | 1 | 2017 | 35 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1303 | 0.140 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 1391 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3678 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1051 | 0.130 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 745 | 0.120 |
Why?
|
| Smad4 Protein | 1 | 2015 | 58 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2015 | 37 | 0.120 |
Why?
|
| Integrin alpha2 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 120 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 107 | 0.110 |
Why?
|
| Antigens, CD34 | 1 | 2015 | 111 | 0.110 |
Why?
|
| Genomics | 1 | 2023 | 1678 | 0.110 |
Why?
|
| Enzyme Activation | 1 | 2016 | 651 | 0.110 |
Why?
|
| Cytosine | 1 | 2014 | 59 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2015 | 645 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1135 | 0.110 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 47 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 160 | 0.110 |
Why?
|
| Paracrine Communication | 1 | 2013 | 74 | 0.100 |
Why?
|
| Small Molecule Libraries | 2 | 2024 | 138 | 0.100 |
Why?
|
| Ovary | 1 | 2015 | 390 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2015 | 811 | 0.100 |
Why?
|
| Wnt Proteins | 1 | 2013 | 226 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 208 | 0.090 |
Why?
|
| Pregnancy Proteins | 1 | 2012 | 14 | 0.090 |
Why?
|
| Placental Circulation | 1 | 2012 | 25 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 830 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 232 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2017 | 845 | 0.090 |
Why?
|
| Oogenesis | 1 | 2012 | 57 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 108 | 0.090 |
Why?
|
| Prostaglandins | 1 | 2011 | 48 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 239 | 0.090 |
Why?
|
| Endothelium | 1 | 2011 | 70 | 0.090 |
Why?
|
| Ovulation | 1 | 2012 | 114 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 247 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 225 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 937 | 0.080 |
Why?
|
| Fetal Development | 1 | 2012 | 135 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 2669 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1538 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2015 | 3180 | 0.080 |
Why?
|
| Male | 8 | 2021 | 66195 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 914 | 0.080 |
Why?
|
| Fetal Growth Retardation | 1 | 2011 | 257 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8639 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 524 | 0.070 |
Why?
|
| Penis | 1 | 2009 | 104 | 0.070 |
Why?
|
| Genome, Human | 2 | 2014 | 1350 | 0.070 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 478 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1783 | 0.070 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 268 | 0.070 |
Why?
|
| Fetus | 1 | 2011 | 601 | 0.070 |
Why?
|
| Adult | 9 | 2015 | 31947 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4882 | 0.070 |
Why?
|
| Middle Aged | 8 | 2015 | 29413 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 2178 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2009 | 213 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2735 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2015 | 433 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.050 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2023 | 5 | 0.050 |
Why?
|
| Beclin-1 | 1 | 2023 | 29 | 0.050 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2024 | 148 | 0.050 |
Why?
|
| Base Sequence | 3 | 2012 | 3180 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2024 | 179 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 15 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2023 | 104 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2023 | 198 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 211 | 0.050 |
Why?
|
| Granulosa Cells | 1 | 2023 | 142 | 0.050 |
Why?
|
| Gene Library | 1 | 2023 | 225 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2013 | 318 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2024 | 467 | 0.050 |
Why?
|
| Myometrium | 2 | 2012 | 48 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2024 | 399 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 1109 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 546 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2013 | 615 | 0.050 |
Why?
|
| Oocytes | 1 | 2023 | 302 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1332 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 920 | 0.040 |
Why?
|
| Autophagy | 1 | 2023 | 429 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 1138 | 0.040 |
Why?
|
| Stem Cells | 1 | 2023 | 754 | 0.040 |
Why?
|
| Young Adult | 1 | 2012 | 9961 | 0.030 |
Why?
|
| Inhibin-beta Subunits | 1 | 2017 | 20 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 100 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2017 | 163 | 0.030 |
Why?
|
| PPAR-beta | 1 | 2015 | 4 | 0.030 |
Why?
|
| PPAR delta | 1 | 2015 | 10 | 0.030 |
Why?
|
| Retinoids | 1 | 2015 | 32 | 0.030 |
Why?
|
| Vascular Remodeling | 1 | 2015 | 54 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 402 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2014 | 34 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 233 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 260 | 0.030 |
Why?
|
| Axin Protein | 1 | 2013 | 18 | 0.030 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2013 | 25 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 357 | 0.020 |
Why?
|
| CpG Islands | 1 | 2014 | 347 | 0.020 |
Why?
|
| Blood Cells | 1 | 2012 | 55 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2012 | 9 | 0.020 |
Why?
|
| Perilipin-2 | 1 | 2012 | 10 | 0.020 |
Why?
|
| Nucleotide Motifs | 1 | 2012 | 48 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2012 | 62 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 120 | 0.020 |
Why?
|
| Muscle Tonus | 1 | 2011 | 5 | 0.020 |
Why?
|
| Mifepristone | 1 | 2012 | 139 | 0.020 |
Why?
|
| Mediator Complex | 1 | 2012 | 61 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 246 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2011 | 75 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2011 | 103 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 672 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 228 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2012 | 186 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 180 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 273 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 371 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 1044 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 624 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2538 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 548 | 0.020 |
Why?
|
| Lidocaine | 1 | 2009 | 48 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1386 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 1434 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 539 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 1764 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 2265 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3978 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 1259 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1721 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 487 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1308 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 1835 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2915 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3800 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1621 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3876 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1945 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2771 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 6350 | 0.010 |
Why?
|
| United States | 1 | 2012 | 11798 | 0.010 |
Why?
|